The authors focus on the signaling pathways, and molecular mechanisms involved in FOXO1 regulation in lung cancer, and discuss pharmacological compounds that are currently being administered for lung cancer treatment by affecting FOXO1.
[Biomedicine & Pharmacotherapy]